From Phage lambda to human cancer: endogenous molecular-cellular network hypothesis

Quantitative Biology

Volumn 1, Issue 1, 2013, Pages 32-49

  Wang, Gaowei ^a,b   Zhu, Xiaomei ^c   Hood, Leroy ^d   Ao, Ping ^a,b,e  

^a Chinese National Human Genome Center at Shanghai   (China)

^b SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^c GenMath Corp   (United States)

^d INSTITUTE FOR SYSTEMS BIOLOGY   (United States)

^e SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Adaptive Landscape; Genetic Switch; Intrinsic State; Phage Lambda; Regulatory Machinery

Indexed keywords

EID: 84931037043     PISSN: 20954689     EISSN: 20954697     Source Type: Journal    
DOI: 10.1007/s40484-013-0007-1     Document Type: Review

References (111)

1. Kumar, V., Robbins, S., Zhai, Q. and Chen, J. (2009) Textbook of Pathology. Peking University Medical Press.
2. Hajdu, S. I. (2011) A note from history: landmarks in history of cancer, part 1. Cancer, 117, 1097–1102.
3. Ao, P., Galas, D., Hood, L. and Zhu, X. (2008) Cancer as robust intrinsic state of endogenous molecular-cellular network shaped by evolution. Med. Hypotheses, 70, 678–684.
4. Hanahan, D. and Weinberg, R. A. (2011) Hallmarks of cancer: the next generation. Cell, 144, 646–674.
5. Nowell, P. C. (1976) The clonal evolution of tumor cell populations. Science, 194, 23–28.
6. Greaves, M. and Maley, C. C. (2012) Clonal evolution in cancer. Nature, 481, 306–313.
7. Hou, Y., Song, L., Zhu, P., Zhang, B., Tao, Y., Xu, X., Li, F., Wu, K., Liang, J., Shao, D., et al. (2012) Single-cell exome sequencing and monoclonal evolution of a JAK2-negative myeloproliferative neoplasm. Cell, 148, 873–885.
8. Land, H., Parada, L. F. and Weinberg, R. A. (1983) Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes. Nature, 304, 596–602.
9. Weinberg, R. A. (1995) The retinoblastoma protein and cell cycle control. Cell, 81, 323–330.
10. Paget, S. (1989) The distribution of secondary growths in cancer of the breast. 1889. Cancer Metastasis Rev., 8, 98–101.
11. Fidler, I. J. and Poste, G. (2008) The “seed and soil” hypothesis revisited. Lancet Oncol., 9, 808.
12. Wang, X., Ouyang, H., Yamamoto, Y., Kumar, P. A., Wei, T. S., Dagher, R., Vincent, M., Lu, X., Bellizzi, A. M., Ho, K. Y., et al. (2011) Residual embryonic cells as precursors of a Barrett’s-like metaplasia. Cell, 145, 1023–1035.
13. Koshland, D. E. Jr, Goldbeter, A. and Stock, J. B. (1982) Amplification and adaptation in regulatory and sensory systems. Science, 217, 220–225.
14. Ao, P. (2009) Global view of bionetwork dynamics: adaptive landscape. J. Genet. Genomics, 36, 63–73.
15. Li, F., Long, T., Lu, Y., Ouyang, Q. and Tang, C. (2004) The yeast cellcycle network is robustly designed. Proc. Natl. Acad. Sci. USA, 101, 4781–4786.
16. Zhu, X. M., Yin, L., Hood, L. and Ao, P. (2004) Robustness, stability and efficiency of phage lambda genetic switch: dynamical structure analysis. J. Bioinform. Comput. Biol., 2, 785–817.
17. Zhu, X., Yin, L., Hood, L., Galas, D. and Ao, P. (2007) Efficiency, robustness, and stochasticity of gene regulatory networks in systems biology: λ switch as a working example. In Choi, S. (ed.), Introduction to Systems Biology. Humana Press, 336–371.
18. Bizzarri, M., Giuliani, A., Cucina, A., D’Anselmi, F., Soto, A. M. and Sonnenschein, C. (2011) Fractal analysis in a systems biology approach to cancer. Semin. Cancer Biol., 21, 175–182.
19. Pastan, I. and Gottesman, M. (1987) Multiple-drug resistance in human cancer. N. Engl. J. Med., 316, 1388–1393.
20. Gimbrone, M. A. Jr, Leapman, S. B., Cotran, R. S. and Folkman, J. (1972) Tumor dormancy in vivo by prevention of neovascularization. J. Exp. Med., 136, 261–276.
21. Hartwell, L. H., Hopfield, J. J., Leibler, S. and Murray, A. W. (1999) From molecular to modular cell biology. Nature, 402, C47–C52.
22. Akhurst, R. J. and Derynck, R. (2001) TGF-β signaling in cancer-a double-edged sword. Trends Cell Biol., 11, S44–S51.
23. Feng, G.-S. (2012) Conflicting roles of molecules in hepatocarcinogenesis: paradigm or paradox. Cancer Cell, 21, 150–154.
24. Kauffman, S. (2008) Control circuits for determination and transdetermination: interpreting positional information in a binary epigenetic code. In Porter, R. and Rivers J. (eds.), Ciba Foundation Symposium 29 — Cell Patterning. John Wiley & Sons, Ltd., 201–221.
25. Auffray, C., Chen, Z. and Hood, L. (2009) Systems medicine: the future of medical genomics and healthcare. Genome Med., 1, 2.
26. Chalancon, G., Ravarani, C. N. J., Balaji, S., Martinez-Arias, A., Aravind, L., Jothi, R. and Babu, M. M. (2012) Interplay between gene expression noise and regulatory network architecture. Trends Genet., 28, 221–232.
27. Hood, L. and Flores, M. (2012) A personal view on systems medicine and the emergence of proactive P4 medicine: predictive, preventive, personalized and participatory. New Biotechnol., 29, 613–624.
28. Vital-Lopez, F., Memišević, V. and Dutta, B. (2012) Tutorial on biological networks. Wiley Interdiscip. Rev. Data Min. Knowl. Discov., 2, 298–325.
29. Ao, P., Galas, D., Hood, L., Yin, L. and Zhu, X. M. (2010) Towards predictive stochastic dynamical modeling of cancer genesis and progression. Interdiscip. Sci., 2, 140–144.
30. Nurse, P. (2000) A long twentieth century of the cell cycle and beyond. Cell, 100, 71–78.
31. Garber, K. (2001) Beyond the Nobel Prize: cell cycle research offers new view of cancer. J. Natl. Cancer Inst., 93, 1766–1768.
32. Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K. and Yamanaka, S. (2007) Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell, 131, 861–872.
33. Huang, P., He, Z., Ji, S., Sun, H., Xiang, D., Liu, C., Hu, Y., Wang, X. and Hui, L. (2011) Induction of functional hepatocyte-like cells from mouse fibroblasts by defined factors. Nature, 475, 386–389.
34. Tyson, J. J. and Novak, B. (2008) Temporal organization of the cell cycle. Curr. Biol., 18, R759–R768.
35. Spencer, S. L. and Sorger, P. K. (2011) Measuring and modeling apoptosis in single cells. Cell, 144, 926–939.
36. R3: their roles in mediating the effects of repressor and cro. J. Mol. Biol., 139, 163–194.
37. Yuh, C. H., Bolouri, H. and Davidson, E. H. (1998) Genomic cisregulatory logic: experimental and computational analysis of a sea urchin gene. Science, 279, 1896–1902.
38. Baker, S. G. and Kramer, B. S. (2011) Systems biology and cancer: promises and perils. Prog. Biophys. Mol. Biol., 106, 410–413.
39. Alberts, B., Johnson A., Lewis J., Raff M., Roberts K. and Walter P. (2007) Molecular Biology of the Cell (5th ed.). Garland Science.
40. Smale, S., Hirsch, M. and Devaney, R. (2003) Differential Equations, Dynamical Systems, and an Introduction to Chaos. Elsevier Science.
41. Bar-Yam, Y., Harmon, D. and de Bivort, B. (2009) Attractors and democratic dynamics. Science, 323, 1016–1017.
42. Ao, P. (2005) Laws in Darwinian evolutionary theory. Phys. Life Rev., 2, 117–156.
43. Schäfer, M. and Werner, S. (2008) Cancer as an overhealing wound: an old hypothesis revisited. Nat. Rev. Mol. Cell Biol., 9, 628–638.
44. Williams, C. S., Mann, M. and DuBois, R. N. (1999) The role of cyclooxygenases in inflammation, cancer, and development. Oncogene, 18, 7908–7916.
45. Neidhardt, F. (1987) Escherichia Coli and Salmonella Typhimurium: Cellular and Molecular Biology. American Society for Microbiology.
46. Cairns, J., Stent, G. S. and Watson, J. D. (2007) Phage and the Origins of Molecular Biology (The Centennial Edition). Cold Spring Harbor Laboratory Press.
47. Ptashne, M. (2004) A Genetic Switch: Phage Lambda Revisited. Cold Spring Harbor Laboratory Press.
48. Shea, M. A. and Ackers, G. K. (1985) The OR control system of bacteriophage lambda: a physical-chemical model for gene regulation. J. Mol. Biol., 181, 211–230.
49. Waddington, C. (1957) The Strategy of the Genes: A Discussion of Some Aspects of Theoretical Biology. Allen & Unwin.
50. Wright, S. (1982) The shifting balance theory and macroevolution. Annu. Rev. Genet., 16, 1–19.
51. Wang, J., Zhang, K., Xu, L. and Wang, E. (2011) Quantifying the Waddington landscape and biological paths for development and differentiation. Proc. Natl. Acad. Sci. USA, 108, 8257–8262.
52. Cao, Y., Lu, H. M. and Liang, J. (2010) Probability landscape of heritable and robust epigenetic state of lysogeny in phage lambda. Proc. Natl. Acad. Sci. USA, 107, 18445–18450.
53. Bryngelson, J. D., Onuchic, J. N., Socci, N. D. and Wolynes, P. G. (1995) Funnels, pathways, and the energy landscape of protein folding: a synthesis. Proteins: Struct. Func. Bioinfo., 21, 167–195.
54. Ao, P., Kwon, C. and Qian, H. (2007) On the existence of potential landscape in the evolution of complex systems. Complexity, 12, 19–27.
55. Yuan, R. S. and Ao, P. (2012) Beyond Itô versus Stratonovich. J. Stat. Mech., 2012, P07010.
56. Tian, W., Zhu, H., Lei, X. and Ao, P. (2011) Extrinsic vs. intrinsic noises in Phage lambda genetic switch. In Proceedings of 2011 IEEE Conference on Systems Biology. 67–71.
57. El-Serag, H. B. and Rudolph, K. L. (2007) Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology, 132, 2557–2576.
58. Parkin, D. M., Bray, F., Ferlay, J. and Pisani, P. (2005) Global cancer statistics, 2002. CA Cancer J. Clin., 55, 74–108.
59. Monga, S. and Cagle, P. (2010) Molecular Pathology of Liver Diseases. Springer.
60. Michalopoulos, G. (2011) Liver regeneration. In 机构Monga, S. P. S. (ed.), Molecular Pathology of Liver Diseases. Springer US, 5, 261–278
61. Higgins, G. M. (1931) Experimental pathology of the liver: I. Restoration of the liver of the while rat following surgical removal. Arch. Pathol. (Chic), 12, 186–202.
62. Grisham, J. W. (1962) A morphologic study of deoxyribonucleic acid synthesis and cell proliferation in regenerating rat liver; autoradiography with thymidine-H3. Cancer Res., 22, 842–849.
63. Wang, H., Iakova, P., Wilde, M., Welm, A., Goode, T., Roesler, W. J. and Timchenko, N. A. (2001) C/EBPα arrests cell proliferation through direct inhibition of Cdk2 and Cdk4. Mol. Cell, 8, 817–828.
64. Ilyin, G. P., Glaise, D., Gilot, D., Baffet, G. and Guguen-Guillouzo, C. (2003) Regulation and role of p21 and p27 cyclin-dependent kinase inhibitors during hepatocyte differentiation and growth. Am. J. Physiol. Gastrointest. Liver Physiol., 285, G115–G127.
65. Papakyriakou, P., Tzardi, M., Valatas, V., Kanavaros, P., Karydi, E., Notas, G., Xidakis, C. and Kouroumalis, E. (2002) Apoptosis and apoptosis related proteins in chronic viral liver disease. Apoptosis, 7, 133–141.
66. Wilson, N. S., Dixit, V. and Ashkenazi, A. (2009) Death receptor signal transducers: nodes of coordination in immune signaling networks. Nat. Immunol., 10, 348–355.
67. Green, D. R. and Kroemer, G. (2004) The pathophysiology of mitochondrial cell death. Science, 305, 626–629.
68. Adams, J. M. and Cory, S. (1998) The Bcl-2 protein family: arbiters of cell survival. Science, 281, 1322–1326.
69. Walensky, L. D., Pitter, K., Morash, J., Oh, K. J., Barbuto, S., Fisher, J., Smith, E., Verdine, G. L. and Korsmeyer, S. J. (2006) A stapled BID BH3 helix directly binds and activates BAX. Mol. Cell, 24, 199–210.
70. Jost, P. J., Grabow, S., Gray, D., McKenzie, M. D., Nachbur, U., Huang, D. C., Bouillet, P., Thomas, H. E., Borner, C., Silke, J., et al. (2009) XIAP discriminates between type I and type II FAS-induced apoptosis. Nature, 460, 1035–1039.
71. Wei, M. C., Zong, W. X., Cheng, E. H., Lindsten, T., Panoutsakopoulou, V., Ross, A. J., Roth, K. A., MacGregor, G. R., Thompson, C. B. and Korsmeyer, S. J. (2001) Proapoptotic BAX and BAK: a requisite gateway to mitochondrial dysfunction and death. Science, 292, 727–730.
72. Du, C., Fang, M., Li, Y., Li, L. and Wang, X. (2000) Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition. Cell, 102, 33–42.
73. Zhao, Z., Yang, P., Eckert, R. L. and Reece, E. A. (2009) Caspase-8: a key role in the pathogenesis of diabetic embryopathy. Birth Defects Res. B Dev. Reprod. Toxicol., 86, 72–77.
74. Trautwein, C., Böker, K. and Manns, M. P. (1994) Hepatocyte and immune system: acute phase reaction as a contribution to early defence mechanisms. Gut, 35, 1163–1166.
75. Diehl, A. M. (2000) Cytokine regulation of liver injury and repair. Immunol. Rev., 174, 160–171.
76. Ben-Neriah, Y. and Karin, M. (2011) Inflammation meets cancer, with NF-κB as the matchmaker. Nat. Immunol., 12, 715–723.
77. Schwabe, R. F. and Brenner, D. A. (2006) Mechanisms of Liver Injury. I. TNF-α-induced liver injury: role of IKK, JNK, and ROS pathways. Am. J. Physiol. Gastrointest. Liver Physiol., 290, G583–G589.
78. Sakurai, T., He, G., Matsuzawa, A., Yu, G.-Y., Maeda, S., Hardiman, G. and Karin, M. (2008) Hepatocyte necrosis induced by oxidative stress and IL-1α release mediate carcinogen-induced compensatory proliferation and liver tumorigenesis. Cancer Cell, 14, 156–165.
79. Bromberg, J. and Wang, T. C. (2009) Inflammation and cancer: IL-6 and STAT3 complete the link. Cancer Cell, 15, 79–80.
80. Louis, H., Le Moine, O., Goldman, M. and Devière, J. (2003) Modulation of liver injury by interleukin-10. Acta Gastroenterol. Belg., 66, 7–14.
81. Cairns, R. A., Harris, I. S. and Mak, T. W. (2011) Regulation of cancer cell metabolism. Nat. Rev. Cancer, 11, 85–95.
82. Vander Heiden, M. G., Cantley, L. C. and Thompson, C. B. (2009) Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science, 324, 1029–1033.
83. Semenza, G. (2010) HIF-1: upstream and downstream of cancer metabolism. Curr. Opin. Genet. Dev., 20, 51–56.
84. Lau, C. K., Yang, Z. F., Ho, D.W., Ng, M. N., Yeoh, G. C., Poon, R. T. and Fan, S. T. (2009) An Akt/hypoxia-inducible factor-1α/plateletderived growth factor-BB autocrine loop mediates hypoxia-induced chemoresistance in liver cancer cells and tumorigenic hepatic progenitor cells. Clin. Cancer Res., 15, 3462–3471.
85. Adams, R. H. and Alitalo, K. (2007) Molecular regulation of angiogenesis and lymphangiogenesis. Nat. Rev. Mol. Cell Biol., 8, 464–478.
86. Carmeliet, P., Ferreira, V., Breier, G., Pollefeyt, S., Kieckens, L., Gertsenstein, M., Fahrig, M., Vandenhoeck, A., Harpal, K., Eberhardt, C., et al. (1996) Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature, 380, 435–439.
87. Massagué, J. (1998) TGF-β signal transduction. Annu. Rev. Biochem., 67, 753–791.
88. Lu, Z., Ghosh, S., Wang, Z. and Hunter, T. (2003) Downregulation of caveolin-1 function by EGF leads to the loss of E-cadherin, increased transcriptional activity of β-catenin, and enhanced tumor cell invasion. Cancer Cell, 4, 499–515.
89. Odom, D. T., Dowell, R. D., Jacobsen, E. S., Nekludova, L., Rolfe, P. A., Danford, T.W., Gifford, D. K., Fraenkel, E., Bell, G. I. and Young, R. A. (2006) Core transcriptional regulatory circuitry in human hepatocytes. Mol. Syst. Biol., 2, 2006.0017.
90. Lu, T. T., Makishima, M., Repa, J. J., Schoonjans, K., Kerr, T. A., Auwerx, J. and Mangelsdorf, D. J. (2000) Molecular basis for feedback regulation of bile acid synthesis by nuclear receptors. Mol. Cell, 6, 507–515.
91. Vellela, M. and Qian, H. (2009) Stochastic dynamics and nonequilibrium thermodynamics of a bistable chemical system: the Schlögl model revisited. J. R. Soc. Interface, 6, 925–940.
92. Rosenfeld, S. (2011) Mathematical descriptions of biochemical networks: stability, stochasticity, evolution. Prog. Biophys. Mol. Biol., 106, 400–409.
93. Villarreal, C., Padilla-Longoria, P., and Alvarez-Buylla, E. R. (2012) General theory of genotype to phenotype mapping: derivation of epigenetic landscapes from N-node complex gene regulatory networks. Phys. Rev. Lett., 109, 118102.
94. Xu, X. R., Huang, J., Xu, Z. G., Qian, B. Z., Zhu, Z. D., Yan, Q., Cai, T., Zhang, X., Xiao, H. S., Qu, J., et al. (2001) Insight into hepatocellular carcinogenesis at transcriptome level by comparing gene expression profiles of hepatocellular carcinoma with those of corresponding noncancerous liver. Proc. Natl. Acad. Sci. USA, 98, 15089–15094.
95. Yang, W., Yan, H. X., Chen, L., Liu, Q., He, Y. Q., Yu, L. X., Zhang, S. H., Huang, D. D., Tang, L., Kong, X. N., et al. (2008) Wnt/β-catenin signaling contributes to activation of normal and tumorigenic liver progenitor cells. Cancer Res., 68, 4287–4295.
96. Holmes, P. (2005) Ninety plus thirty years of nonlinear dynamics: less is more and more is different. Int. J. Bifurcat. Chaos, 15, 2703–2716.
97. Ao, P. (2007) Darwinian dynamics implies developmental ascendency. Biol. Theory, 2, 113–115.
98. Ao, P. (2007) Orders of magnitude change in phenotype rate caused by mutation. Cell. Oncol., 29, 67–69.
99. Lee, L., Yin, L., Zhu, X. and Ao, P. (2007) Generic enzymatic rate equation under living conditions. J. Biol. Syst., 15, 495–514.
100. Ao, P., Lee, L. W., Lidstrom, M. E., Yin, L. and Zhu, X. (2008) Towards kinetic modeling of global metabolic networks: methylobacterium extorquens AM1 growth as validation. Chin. J. Biotechnol., 24, 980–994.
101. Liu, C., Fan, D., Shi, Y. and Zhou, Q. (2012) A glimpse of enzymology within the idea of systems. Sci. China Life Sci., 55, 826–833.
102. Huang, S. (2011) On the intrinsic inevitability of cancer: from foetal to fatal attraction. Semin. Cancer Biol., 21, 183–199.
103. Zhou, J. X., Aliyu, M. D., Aurell, E. and Huang, S. (2012) Quasipotential landscape in complex multi-stable systems. J. R. Soc. Interface, 9, 3539–3553.
104. Baverstock, K. and Karotki, A. V. (2011) Towards a unifying theory of late stochastic effects of ionizing radiation. Mutat. Res., 718, 1–9.
105. Davies, P. C. W. and Lineweaver, C. H. (2011) Cancer tumors as Metazoa 1.0: apping genes of ancient ancestors. Phys. Biol., 8, 015001.
106. Vincent, M. D. (2011) Cancer: beyond speciation. Adv. Cancer Res., 112, 283–350.
107. Chaffer, C. L., Brueckmann, I., Scheel, C., Kaestli, A. J., Wiggins, P. A., Rodrigues, L. O., Brooks, M., Reinhardt, F., Su, Y., Polyak, K., et al. (2011) Normal and neoplastic nonstem cells can spontaneously convert to a stem-like state. Proc. Natl. Acad. Sci. USA, 108, 7950–7955.
108. Gupta, P. B., Fillmore, C. M., Jiang, G., Shapira, S. D., Tao, K., Kuperwasser, C. and Lander, E. S. (2011) Stochastic state transitions give rise to phenotypic equilibrium in populations of cancer cells. Cell, 146, 633–644.
109. Heng, H. H. Q., Liu, G., Stevens, J. B., Bremer, S. W., Ye, K. J., Abdallah, B. Y., Horne, S. D. and Ye, C. J. (2011) Decoding the genome beyond sequencing: the new phase of genomic research. Genomics, 98, 242–252.
110. Gerstein, M. B., Kundaje, A., Hariharan, M., Landt, S. G., Yan, K.-K., Cheng, C., Mu, X. J., Khurana, E., Rozowsky, J., Alexander, R., et al. (2012) Architecture of the human regulatory network derived from ENCODE data. Nature, 489, 91–100.
111. Yamanaka, S. (2009) Elite and stochastic models for induced pluripotent stem cell generation. Nature, 460, 49–52.